1/21
Vocabulary flashcards covering fundamental immunology concepts, leukocyte biology, immunoglobulin properties, antibody fragments, tumor antigens, and methods for monoclonal antibody generation from the lecture exam.
Neutrophil
The most abundant type of leukocyte found in human peripheral blood.
T-Cell Lymph Node Recirculation
The pathway whereby naive T cells enter a lymph node via the bloodstream and exit via the efferent lymphatics.
Blood Plasma
The liquid component of blood consisting of 90% water along with salts, enzymes, antibodies, other proteins, and clotting factors.
Immunoglobulin A (IgA)
The antibody isotype that is transported most efficiently across mucosal epithelium and neutralizes microbial toxins and animal venoms.
Somatic Recombination
The process of rearranging V, D, and J gene segments that is responsible for generating the diversity of antigen-binding sites in both T-cell receptors and immunoglobulins.
CD8-Positive T Cells
A T-cell subpopulation specialized to combat intracellular pathogens recognized as peptides presented on MHC Class 1 molecules.
CD4-Positive T Cells
A T-cell subpopulation specialized to combat extracellular pathogens recognized as peptides presented on MHC Class 2 molecules.
Innate Immunity
The non-specific, fast-responding first line of defense against infecting microorganisms, utilizing elements such as lysozyme, granulocytes, NK cells, and PAMP recognition.
T-Cell Receptor (TCR)
An antigen receptor resembling a membrane-bound Fab fragment that possesses 1 antigen-binding site and recognizes antigen only as a peptide bound to an MHC molecule.
Immunoglobulin G (IgG)
The most abundant antibody isotype, possessing 2 antigen-binding sites, which confers passive immunity to a newborn via placental transfer during pregnancy.
Single-Chain Variable Fragment (scFv)
An engineered antibody fragment consisting of linked variable domains (VH and VL) that contains 6 complementarity-determining regions (CDRs) contributing to its antigen-binding site.
Germinal Center
The specialized microenvironment within secondary lymphoid organs where activated B cells undergo somatic hypermutation (SHM) and class switch recombination (CSR).
Intraperitoneal Injection (IP)
A route of administration that involves the injection of a substance directly into the peritoneum (body cavity).
Tumor-Associated Antigens (TAAs)
Proteins that are significantly over-expressed in cancer cells compared to normal cells (such as CEA, CA-125, HER-2, and EGFR) rather than being true tumor-specific antigens.
Tumor-Specific Antigens (TSAs)
Neoantigens arising from genetic mutations in cancer cells that lead to the expression of sequence-modified proteins on the cell surface.
Polyethylene Glycol (PEG)
A chemical fusogen applied to mediate cell fusion between mortal splenic B cells and immortal myeloma cells during hybridoma generation.
HAT Medium
A selective culture medium containing hypoxanthine, aminopterin, and thymidine used to select for fused hybridoma cells while eliminating unfused myeloma cells.
Monoclonal Antibody Suffix Nomenclature
The standardized naming convention denoting antibody origin: -momab for mouse antibodies, -ximab for chimeric antibodies, -zumab for humanized antibodies, and -umab for fully human antibodies.
Antibody-Dependent Cellular Cytotoxicity (ADCC)
An immune mechanism where effector cells bearing Fc receptors recognize target cells bound by specific antibodies, triggering degranulation, lysis, and apoptosis.
Natural Killer (NK) Cell in ADCC
An innate effector cell that engages antibody-coated target cells to provide antitumor and abnormal cell destruction by secreting perforins and granzymes.
Phage Display
A method for generating monoclonal antibodies by cloning antibody gene libraries (such as scFv or Fab) into bacteriophages to express fragments on their surface, followed by biopanning and ELISA screening.
Single B-Cell Isolation
A monoclonal antibody discovery technique where target-specific B cells are isolated from peripheral blood via flow cytometry, followed by sequencing, RT-PCR amplification, and recombinant cloning of VDJ and VJ genes.